Clinical Trials Browser

Phase 4 × Not yet recruiting × Cisplatin × Clear all

NCT06951841 2025-04-30

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Phase 4 Not yet recruiting

Small Cell Lung Carcinoma

NCT06931145 2025-04-23

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Phase 4 Not yet recruiting

Small Cell Lung Carcinoma

NCT06485739 2024-07-03

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

Phase 4 Not yet recruiting

Neuroendocrine Tumors

NCT06388135 2024-04-29

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Phase 4 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma